Project Grant HT94252410317
Award Date 9/30/24
Completion Date 9/29/27
Dollars Obligated $626K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
- Project Grant Summary Emory University received a $626,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 15, 2025, through July 14, 2027. The project, titled "Immune-Competent 3D Bioprinted Organoids to Study and Target Barriers to Cellular Therapy for Neuroblastoma," focuses on developing advanced bioprinted three-dimensional (3D) organoid models that incorporate immune system...
- The Defense Health Agency awarded Emory University a $156,500 project grant under the Military Medical Research and Development program to support research on core transcription factors in regenerative medicine and cancer. The one-year award beginning September 30, 2023 will fund investigation into medical solutions for the battlefield by transforming healthcare through innovative biomedical research. Specifically, Emory University will conduct research on core transcription factors as they...
- The Defense Health Agency awarded Emory University a $305,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a novel therapeutic target for renal medullary carcinoma. The award period runs from July 1, 2023 to June 30, 2026. As a leading research university, Emory has a strong track record of delivering scientific research and public health services under federal grants and contracts. This award supports Emory's expertise in...
- This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $187,800.00 to Emory University to conduct research on "Enhancing Radiosensitivity in CHD5-Depleted Lung Adenocarcinoma Through Inhibition of Nonhomologous End Joining (NHEJ)." The research project, which has a performance period from Mar 15, 2025 to Mar 14, 2026, aims to investigate innovative medical solutions for transforming healthcare for military...
- Federal Grant Award Summary Emory University's Office of Sponsored Programs received a $585,759 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2028. The research project, "Targeting GPNMB to Improve Efficacy of CDK4/6 Inhibitors in ER+ Breast Cancer," will be conducted at Emory's Atlanta, Georgia campus. This three-year award supports advanced biomedical...
- Emory University was awarded a $586,875 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 to August 31, 2026 to elucidate and exploit SAMHD1 for breast cancer therapy. Through this funding, Emory University researchers will investigate medical solutions for breast cancer by exploring the role of the SAMHD1 protein and developing new therapeutic approaches for...
- Emory University was awarded a $586,875 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 to August 31, 2026 to elucidate and exploit SAMHD1 for breast cancer therapy. Through this funding, Emory University researchers will investigate medical solutions for breast cancer by exploring the role of the SAMHD1 protein and developing new therapeutic approaches for...
- Federal Project Grant Award Summary Emory University received a $3.13 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the therapeutic application of human induced pluripotent stem cell-derived lymphatic endothelial cells for lymphedema treatment. The award, effective May 1, 2025 through April 30, 2029, supports advanced biomedical research aimed at developing novel therapeutic interventions...
- Federal Grant Award Summary Emory University received a $313,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop macrophage-delivered amino acid degraders for glioblastoma (GBM) therapy. The award, effective July 15, 2025, with a completion date of July 14, 2027, supports advanced biomedical research aimed at developing novel therapeutic interventions for a critical health challenge relevant to military...
- Federal Grant Award Summary Award Details: Emory University received a $156,049 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project "Establishing Epigenetic Markers in Neurofibromatosis." The award, dated October 1, 2025, has a performance period of one year, concluding September 30, 2026. The research will be conducted at Emory University's Atlanta, Georgia campus through the Office of Sponsored...